Case Summary-
On March 17, 2020, the Federal Circuit found that patents claiming methods of preparing an extracellular fraction of cell-free DNA that is enriched in fetal DNA were patent eligible and not invalid under 35...more
6/25/2020
/ Appeals ,
Ariosa ,
CLS Bank v Alice Corp ,
DNA ,
Human Genes ,
Life Sciences ,
Mayo v. Prometheus ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Product of Nature Doctrine ,
Section 101 ,
Treatment Method Patents